Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 77

1. Dermatologic adverse events in EGFR-TKIs: A real-world analysis. Journal of Clinical Oncology · 2024
2. Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects Current drug metabolism · 2009 · 508 citations
3. The PDGF/PDGFR pathway as a drug target Molecular Aspects of Medicine · 2017 · 182 citations
4. Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Dermatology · 2015 · 32 citations
5. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
6. Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia Journal of the American Academy of Dermatology · 2013 · 25 citations
7. Erlotinib-Associated Alopecia in a Lung Cancer Patient Journal of Thoracic Oncology · 2007 · 8 citations
8. Tyrosine kinase Inhibitors in Dermatology: A Systemic Review Journal of dermatology and dermatitis · 2021 · 1 citations
9. Spotlight commentary: Navigating the cutaneous side effects of chemotherapy British Journal of Clinical Pharmacology · 2025
10. Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib Journal of clinical medicine · 2023

Community

— no results